Literature DB >> 16322695

Dissecting the cellular origins of pancreatic cancer.

Ben Z Stanger1, Yuval Dor.   

Abstract

Although putative premalignant lesions like metaplasia--the replacement of one mature cell type with another--have been identified in a variety of cancers, the normal cellular targets of malignant transformation are largely unknown. Pancreatic ductal adenocarcinoma (PDAC) is a particularly aggressive and lethal cancer. Despite its ductal histology, however, it is unknown whether PDAC originates from pancreatic ducts or another cell type within the pancreas. Recent analysis of mice with pancreas-specific deletion of the PTEN tumor suppressor gene has provided new insight into the mechanism of metaplasia and focuses attention on pancreatic centroacinar cells as candidates for the cellular origin of PDAC. Characterization of the "cell-of-origin" could lead to a better understanding of the molecular substrate for tumor initiation and eventually to early diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16322695     DOI: 10.4161/cc.5.1.2291

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  12 in total

Review 1.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.

Authors:  Lei Cui; Yuezhen Deng; Yefei Rong; Wenhui Lou; Zhengfa Mao; Yuanyuan Feng; Dong Xie; Dayong Jin
Journal:  Tumour Biol       Date:  2011-11-26

3.  Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.

Authors:  Jean-Paul De La O; L Charles Murtaugh
Journal:  Cell Cycle       Date:  2009-06-15       Impact factor: 4.534

Review 4.  Pancreatic cancer.

Authors:  Anirban Maitra; Ralph H Hruban
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

5.  Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.

Authors:  Nils Habbe; Guanglu Shi; Robert A Meguid; Volker Fendrich; Farzad Esni; Huiping Chen; Georg Feldmann; Doris A Stoffers; Stephen F Konieczny; Steven D Leach; Anirban Maitra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

Review 6.  Genetically engineered mouse models of pancreatic cancer.

Authors:  Christoph Benedikt Westphalen; Kenneth P Olive
Journal:  Cancer J       Date:  2012 Nov-Dec       Impact factor: 3.360

7.  Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer.

Authors:  Michael E Mullendore; Jan-Bart Koorstra; Yue-Ming Li; G Johan Offerhaus; Xing Fan; Clark M Henderson; William Matsui; Charles G Eberhart; Anirban Maitra; Georg Feldmann
Journal:  Clin Cancer Res       Date:  2009-03-03       Impact factor: 12.531

8.  Isolation and culture of mouse primary pancreatic acinar cells.

Authors:  Johann Gout; Roxane M Pommier; David F Vincent; Bastien Kaniewski; Sylvie Martel; Ulrich Valcourt; Laurent Bartholin
Journal:  J Vis Exp       Date:  2013-08-13       Impact factor: 1.355

9.  Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9.

Authors:  Shalini Makawita; Apostolos Dimitromanolakis; Antoninus Soosaipillai; Ireena Soleas; Alison Chan; Steven Gallinger; Randy S Haun; Ivan M Blasutig; Eleftherios P Diamandis
Journal:  BMC Cancer       Date:  2013-09-03       Impact factor: 4.430

10.  Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.

Authors:  Nhu-An Pham; Joerg Schwock; Vladimir Iakovlev; Greg Pond; David W Hedley; Ming-Sound Tsao
Journal:  BMC Cancer       Date:  2008-02-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.